Explainer

Is Depression Curable? What Long-Term Recovery Data Show

No formal cure exists, but most depression episodes end and many never return: in a Dutch cohort, an estimated 58% who recovered had no recurrence in 20 years.

Mental Health Stats Research Team 7 min read

Key Takeaways

  • No treatment is formally considered a cure, but most episodes end: an estimated 53% of untreated adult primary-care cases remit within 12 months, per a 2013 meta-analysis[1].53%[1]
  • In a Dutch community cohort, estimated recurrence after recovery reached 42.0% at 20 years, so most people stayed free of a new episode[2].42.0%[2]
  • In 2025, 69.4% of U.S. adults who had ever perceived a mental health problem considered themselves recovered or in recovery[3].69.4%[3]
  • In Canada’s 2012 national survey, 39% of people with a history of depression had reached complete mental health, versus 78% of those without one[4].39%[4]
  • Recovering with lingering symptoms was linked to relapse more than three times faster than symptom-free recovery in a 10-year cohort of treatment-seeking patients[5].3x faster[5]
  • Continuing antidepressants after response lowered relapse from 41% to 18% across 31 trials[6], and acute-phase CBT protected better than stopping medication[7].18%[6]

Is Depression Curable? Doctors Measure Remission Instead

Is depression curable? Medicine does not formally call depression curable, because no treatment guarantees that an episode will never return. What the evidence does show is that most episodes end, many people stay well for decades, and a substantial share return to full mental health.

The National Institute of Mental Health describes treatment as psychotherapy, medication or both, with brain stimulation therapy as an option when those do not reduce symptoms enough[8]. In the 2025 National Survey on Drug Use and Health, 69.4% of U.S. adults who had ever perceived a mental health problem, about 44.1 million people, considered themselves in recovery or recovered[3].

That survey question covers every kind of mental health problem, not depression alone, and recovery is self-defined[3]. Clinical research uses stricter yardsticks. Prevalence figures for the diagnosis itself are on the major depressive disorder page.

A useful answer splits the question in three: whether an episode ends, whether it comes back, and whether a person returns to full well-being afterward. Treatment options themselves are compared in how depression is treated toward remission.

Remission (in depression)

In the studies pooled by a 2013 meta-analysis, remission meant a person no longer met diagnostic criteria or scored below a set threshold on a standardized symptom scale[1]. Recurrence is a new episode after a period of remission. Complete mental health is a stricter standard used in some surveys: no mental illness, substance use disorder or suicidal ideation in the past year, plus near-daily happiness or life satisfaction and good social and psychological well-being[4].

Related Terms

response
relapse
recurrence
residual symptoms
complete mental health

Source: Whiteford et al., Psychological Medicine, 2013; Fuller-Thomson et al., Psychiatry Research, 2016

Does Depression Go Away on Its Own?

Often it does, at least in milder cases. A 2013 meta-analysis of 19 studies estimated that among adults in primary care with untreated major depression, 23% remit within 3 months, 32% within 6 months and 53% within 12 months[1].

Remission was less likely in wait-listed samples, in older adults and in studies with longer follow-up, and more likely in children and adolescents[1]. The authors cautioned that their samples probably over-represented mild-to-moderate depression and that the estimates may not apply to severe depression[1].

An episode ending on its own is not the same as depression being gone for good. The longer-term question is whether it returns.

Can Depression Be Cured Permanently? How Often It Comes Back

Recurrence is the main reason clinicians avoid the word cure. In the Netherlands Mental Health Survey and Incidence Study (NEMESIS), which followed 687 community residents who had recovered from major depression, estimated cumulative recurrence was 13.2% at 5 years, 23.2% at 10 years and 42.0% at 20 years[2].

Read the other way, an estimated 58% had no recurrence over two decades[2]. A second Dutch cohort, NEMESIS-2, found lower figures among 746 people with remitted depression: 4.3% at 5 years, 13.4% at 10 years and 27.1% at 20 years[9].

People recruited from treatment settings fare worse. In a 10-year study of 318 patients with major depression, nearly two-thirds had at least one recurrence, and the risk of recurrence rose 16% with each successive recurrence[10]. The NEMESIS authors described community recurrence risk as high but lower than in clinical samples[2].

In NEMESIS, a new episode came sooner for younger people and for those with more previous episodes, a severe last episode, negative youth experiences or ongoing difficulties[2]. NEMESIS-2 also linked recurrence to childhood abuse, negative life events and parental psychopathology[9].

A minority do not recover at all within a few years: among people with current depression in NEMESIS-2, 12% developed a chronic episode over 6 years[9]. Depression that persists for years without lifting is classified as persistent depressive disorder, and the long-term course is reviewed in our analysis of whether depression is chronic.

How these numbers are measured: Recurrence figures come from cohorts that followed people after they recovered, using structured diagnostic interviews. Community samples include people who never sought treatment and show lower recurrence than clinic samples[2], so where a study recruited matters as much as how long it ran.

Depression Recurrence After Recovery, by Study

StudySettingPeople followedBy 5 yearsBy 10 yearsBy 20 years
NEMESIS (Netherlands)Community68713.2%23.2%42.0%
NEMESIS-2 (Netherlands)Community7464.3%13.4%27.1%
Multicenter clinical cohortClinical318n/aNearly 2 in 3n/a

Estimated cumulative share of adults with a new major depressive episode after recovery. NEMESIS data are from Hardeveld et al., 2013[2]. NEMESIS-2 data are from ten Have et al., 2018[9]. Clinical cohort data are from Solomon et al., 2000[10].

1The clinical cohort reported the share with at least one recurrence during 10 years of follow-up rather than survival estimates at fixed points[10].

2NEMESIS required participants to have been in remission for at least 6 months at baseline and used the Composite International Diagnostic Interview[2].

Sources

  • •Hardeveld et al., Psychological Medicine, 2013
  • •ten Have et al., Acta Psychiatrica Scandinavica, 2018
  • •Solomon et al., American Journal of Psychiatry, 2000
Estimated share of recovered adults in a Dutch community cohort with no recurrence of major depression after 20 years
58%

NEMESIS estimated cumulative recurrence of 42.0% at 20 years, so most people who recovered stayed free of a new episode for two decades. Risk was higher after a severe episode and with more previous episodes.

"The estimated cumulative recurrence of MDD was 13.2% at 5 years, 23.2% at 10 years and 42.0% at 20 years."

Hardeveld et al., Psychological Medicine(2013) View Source

Can You Fully Recover From Depression?

Ending an episode and feeling fully well are different outcomes. In Canada’s 2012 national mental health survey, 39% of people with a history of depression met the criteria for complete mental health, compared with 78% of those with no depression history[4].

Those who had reached complete mental health were more likely to have a confidant, be married, be free of disabling pain and insomnia, exercise regularly and use spirituality to cope[4]. These are cross-sectional associations, and the survey cannot show that any of these factors produced the recovery.

How completely symptoms resolve also predicts what happens next. In a study that followed treatment-seeking patients at five academic centers for 10 years or longer, those who recovered with lingering subthreshold symptoms relapsed to their next major episode more than three times faster than those who recovered symptom-free[5].

Residual symptoms were a stronger predictor of early relapse (odds ratio 3.65) than a history of recurrent episodes (odds ratio 1.64)[5]. The authors found that symptom-free recovery was associated with a prolonged delay before any recurrence[5].

What Lowers the Chance of Depression Returning?

No treatment makes recurrence impossible, but several reduce it measurably. Across 31 randomized trials with 4,410 participants, people who kept taking antidepressants after responding relapsed at a rate of 18%, compared with 41% among those switched to placebo[6].

That was a 70% reduction in the odds of relapse, an effect that seemed to persist for up to 36 months, although most trials lasted 12 months[6]. Drug classes and side effects are compared in our guide to antidepressants.

Can depression be cured without medication?

Psychotherapy appears to have effects that outlast the sessions. A 2013 meta-analysis of 9 studies with 506 patients found that people treated with cognitive behavioral therapy (CBT) in the acute phase were less likely to relapse than people whose medication was stopped (odds ratio 2.61, number needed to treat 5)[7].

Acute-phase CBT did about as well as staying on medication, with a non-significant trend favoring CBT, and the authors urged caution because the studies were few[7]. The therapy is described in our review of CBT for depression.

Mindfulness-based cognitive therapy (MBCT) targets people in remission from recurrent depression. In an individual-patient meta-analysis of 9 trials and 1,258 patients, MBCT lowered the risk of relapse over 60 weeks compared with no MBCT (hazard ratio 0.69) and compared with other active treatments (hazard ratio 0.79)[11].

Is Treatment-Resistant Depression Curable?

When the first treatment fails, later steps still help some people, with diminishing returns. In the STAR*D trial, remission rates were 36.8%, 30.6%, 13.7% and 13.0% across four successive treatment steps, and the investigators reported an overall cumulative remission rate of 67%[12].

That headline figure is disputed. A 2023 reanalysis that followed the trial’s original protocol, using the blinded Hamilton scale, put cumulative remission at 35.0%[13]. In the original report, participants who needed more steps had higher relapse rates during follow-up[12].

Depression that does not improve after several adequate treatments is tracked on the treatment-resistant depression page. NIMH notes that brain stimulation therapies such as electroconvulsive therapy (ECT) and repetitive transcranial magnetic stimulation (rTMS) are options when other treatments have not worked[8]. Their trial results are reviewed in our ECT explainer and our TMS review.

Where the Evidence on Curing Depression Is Thin

The strongest long-term recurrence data come from Dutch community cohorts, and the complete-mental-health estimate comes from a Canadian survey conducted in 2012[4]. None of the community recurrence figures in this article come from U.S. samples.

Several key studies are old: the residual-symptom study was published in 1998[5], and the antidepressant relapse review in 2003[6]. Most relapse-prevention trials in that review lasted 12 months, so evidence on longer treatment needs confirmation[6].

Definitions also differ. A diagnostic interview, a symptom-scale cutoff and a self-report of being recovered measure different things, so the 69.4% NSDUH figure[3] and the 39% Canadian figure[4] cannot be compared directly.

Frequently Asked Questions

Sources & References

  1. Whiteford HA, Harris MG, McKeon G, et al. Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychological Medicine. Published 2013. Accessed October 2026. https://doi.org/10.1017/S0033291712001717 [Link]
  2. Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF. Recurrence of major depressive disorder and its predictors in the general population: results from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Psychological Medicine. Published 2013. Accessed October 2026. https://doi.org/10.1017/S0033291712002395 [Link]
  3. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2025 National Survey on Drug Use and Health. Substance Abuse and Mental Health Services Administration. Published 2026. Accessed October 2026. https://www.samhsa.gov/data/sites/default/files/reports/rpt57150/2025-nsduh-annual-national-report.pdf [Link]
  4. Fuller-Thomson E, Agbeyaka S, LaFond DM, Bern-Klug M. Flourishing after depression: factors associated with achieving complete mental health among those with a history of depression. Psychiatry Research. Published 2016. Accessed October 2026. https://doi.org/10.1016/j.psychres.2016.04.041 [Link]
  5. Judd LL, Akiskal HS, Maser JD, et al. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders. Published 1998. Accessed October 2026. https://doi.org/10.1016/S0165-0327(98)00138-4 [Link]
  6. Geddes JR, Carney SM, Davies C, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. The Lancet. Published 2003. Accessed October 2026. https://doi.org/10.1016/S0140-6736(03)12599-8 [Link]
  7. Cuijpers P, Hollon SD, van Straten A, et al. Does cognitive behaviour therapy have an enduring effect that is superior to keeping patients on continuation pharmacotherapy? A meta-analysis. BMJ Open. Published 2013. Accessed October 2026. https://doi.org/10.1136/bmjopen-2012-002542 [Link]
  8. National Institute of Mental Health. Depression. National Institutes of Health. Published 2024. Accessed October 2026. https://www.nimh.nih.gov/health/publications/depression [Link]
  9. ten Have M, de Graaf R, van Dorsselaer S, et al. Recurrence and chronicity of major depressive disorder and their risk indicators in a population cohort. Acta Psychiatrica Scandinavica. Published 2018. Accessed October 2026. https://doi.org/10.1111/acps.12874 [Link]
  10. Solomon DA, Keller MB, Leon AC, et al. Multiple recurrences of major depressive disorder. American Journal of Psychiatry. Published 2000. Accessed October 2026. https://doi.org/10.1176/appi.ajp.157.2.229 [Link]
  11. Kuyken W, Warren FC, Taylor RS, et al. Efficacy of mindfulness-based cognitive therapy in prevention of depressive relapse: an individual patient data meta-analysis from randomized trials. JAMA Psychiatry. Published 2016. Accessed October 2026. https://doi.org/10.1001/jamapsychiatry.2016.0076 [Link]
  12. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. American Journal of Psychiatry. Published 2006. Accessed October 2026. https://doi.org/10.1176/ajp.2006.163.11.1905 [Link]
  13. Pigott HE, Kim T, Xu C, Kirsch I, Amsterdam J. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research protocol. BMJ Open. Published 2023. Accessed October 2026. https://doi.org/10.1136/bmjopen-2022-063095 [Link]

Related Statistics